myoglobin showed to be a useful marker and a therapeutic ... · myoglobin showed to be a useful...
TRANSCRIPT
Myoglobin showed to be a useful marker and a therapeutic guide in Mb-ARF
Need for HD increased considerably at blood levels 15-20 mg/l
High efficiency of Mb removal by HCO treatment was demonstrated
Rapid fall in serum Mb during HCO HDF was followed by a high rebound
A significant albumin loss into dialysate was observed, demanding substitution
Endogenous metabolic clearance of Mb was slow
Kinetics of Mb release and metabolism is still not well elucidated
HCO treatment might have prevented transition to anuria or shortened the
course of Mb-ARF in some patients; but its clinical benefits remain uncertain
High mortality rate was observed, extremely so in C-V surgery patients
H 1st lab
???
???
???
Clinical consequences of rhabdomyolysis
• Local / systemic muscle fiber destruction
• Complications : AKI, DIC, etc.
• Systemic release of free iron, cytokines & oxygen radicals
• Secondary organ damage ?
• Persistent morbidity ?
• Increased mortality ?
Mb vs Hb : homology
Tomoki Nishiyama, Kazuo Hanaoka. Free hemoglobin concentrations in patients receiving massive blood transfusion during emergency surgery for trauma. Can J Anesth 2000; 47(9):881–885 Larsen R, Gozzelino R,Jeney V, et al. A central role for free heme in the pathogenesis of severe sepsis. Sci Transl Med 2010;2(51):51-71.
SYSTEMIC CONSEQUENCES OF RHABDOMYOLYSIS?
Hb
140 g/l ≈ 21.7 mmol/l
massive blood transfusion (5 l)
free Hb ≈ 4 μmol/l
(1mol Hb = 4 mol heme)
free heme ≈ 16 μmol/l
(Fe++/Fe+++)
Sickle cell crisis
free Hb to ≈ 25μmol/l
free heme ≈ 100 μmol/l
Mb
< 70 μg/l ≈ 4 nmol/l
rhabdomyolysis ↑ ↑ ↑ Mb
(70 mg/l = 1000 x)
free Mb ≈ 4 μmol/l
(1 mol Mb = 1 mol heme)
free heme ≈ 4 μmol/l
(Fe++/Fe+++)
Severe RML
Mb ≈ 200-700 mg/l
free heme ≈
12-40 μmol/l
Mark T. Gladwin, Tamir Kanias, Daniel B. Kim-Shapiro Hemolysis and cell-free hemoglobin drive an intrinsic mechanism for human disease. J Clin Invest. 2012; 122(4):1205–1208
Mb vs Hb : analogy ?
Flögel U, Merx MW, Gödecke A, Decking UK, Schrader J.
Myoglobin: A scavenger of bioactive NO.
Proc Natl Acad Sci USA. 2001; 98: 735-40.
SYSTEMIC CONSEQUENCES OF RHABDOMYOLYSIS?
Richard A Zager, Kirstin M Burkhart, Duane Scott Conrad and Dennis J Gmur. Iron, heme oxygenase, and glutathione: Effects on myohemoglobinuric proximal tubular injury.Kidney Int 1995; 48: 1624-1634; doi:10.1038/ki.1995.457 Zager RA: Heme protein-ischemic interactions at the vascular, intraluminal, and renal tubular cell levels: Implications for therapy of myoglobin-induced renal injury. Renal Failure 1992; 14:341–344 Zager RA, Foerder CA: Effects of inorganic iron and myoglobin on in vitro proximal tubular lipid peroxidation and cytotoxicity. J Clin Invest 1992; 89:989–995 Plotnikov EY, Chupyrkina AA. Pevzner IB, Isaev NK, Zorov DB. Myoglobin causes oxidative stress, increase of NO production and dysfunction of kidney's mitochondria. Biochim Biophys Acta 2009;1792(8):796-803. Epub 2009 Jun 21. Olivier Boutaud, L. Jackson Roberts Mechanism-based therapeutic approaches to rhabdomyolysis-induced renal failure . Free radical biology and Medicine 2011; 51(5):1062-1067. Translational aspects of free radical biology
Byrick RJ, Goldstein MB, Wong PY. Increased plasma tumor necrosis factor concentration in severe rhabdomyolysis is not reduced by continuous
arteriovenous hemodialysis. Crit Care Med, 1992; 20(10):1483-6.
SYSTEMIC CONSEQUENCES OF RHABDOMYOLYSIS?
Richard A Zager, Kirstin M Burkhart, Duane Scott Conrad and Dennis J Gmur. Iron, heme oxygenase, and glutathione: Effects on myohemoglobinuric proximal tubular injury.Kidney Int 1995; 48: 1624-1634; doi:10.1038/ki.1995.457 Zager RA: Heme protein-ischemic interactions at the vascular, intraluminal, and renal tubular cell levels: Implications for therapy of myoglobin-induced renal injury. Renal Failure 1992; 14:341–344 Zager RA, Foerder CA: Effects of inorganic iron and myoglobin on in vitro proximal tubular lipid peroxidation and cytotoxicity. J Clin Invest 1992; 89:989–995 Plotnikov EY, Chupyrkina AA. Pevzner IB, Isaev NK, Zorov DB. Myoglobin causes oxidative stress, increase of NO production and dysfunction of kidney's mitochondria. Biochim Biophys Acta 2009;1792(8):796-803. Epub 2009 Jun 21. Olivier Boutaud, L. Jackson Roberts Mechanism-based therapeutic approaches to rhabdomyolysis-induced renal failure . Free radical biology and Medicine 2011; 51(5):1062-1067. Translational aspects of free radical biology
Predlog SLO raziskave o sistemski toksičnosti rabdomiolize
Namen: ugotoviti lab (+ klinične?) znake sistemske toksičnosti RML
Bolniki z RML z Mb > 5.000 ug/l, verjetno povzročeno s statini, in +/- AOL
- brez akutnih / kroničnih hudih spremljajočih bolezni
(sepsa, AMI, CVI; kronični zapleti AS- IBS, PAOB; DM z zapleti; KOL/HD)
- brez znanih dejavnikov za hemolizo (AVR, hemolitične anemije,…)
Potrebno število vključenih ≈ 40-50, predviden čas ≈ 2-3 leta
Elektronski obrazec raziskave na spletu
Potrebni material
- klinični podatki o bolniku, čas od začetka simptomov, terapija RML +
ostala, Mbt0 in kreatinin, potek bolezni, ev. HD
- zamrznjen prvi vzorec plazme v običajni 7 ml epruveti za biokemijo
- ponovni vzorec naslednji dan in 5. dan
Vzorčenje: Mb, prosti Fe v serumu, prosti hem, hemopeksin, antioksidanti,
NO/NO2
Nove Th možnosti RML?
• ↓ lipidna peroksidacija : acetaminofen
• ↓ ROS (reaktivni kisikovi radikali): niacin, Hx
• Indukcija NO sintaze ↑NO : nitrit, arginin, glutamin,
• ↑ Hx (Hemopexin) = hem scavenger
• Indukcija HO-1: niacin
• Inhibicija adhezijskih molekul ICAM;VCAM
• ↑SOD : erythriol
Želimo vam lep adventni december, prijetne praznike…
In mnogo osebne sreče in delovnih uspehov
v Novem letu!!!